相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Attacking Latent HIV with convertibleCAR-T Cells, a Highly Adaptable Killing Platform
Eytan Herzig et al.
CELL (2019)
Chimeric antigen receptor transduced T cells: Tuning up for the next generation
Maria-Luisa Schubert et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
Sattva S. Neelapu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Cationic polymers for non-viral gene delivery to human T cells
Brynn R. Olden et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Toll-like receptor 9 antagonizes antibody affinity maturation
Munir Akkaya et al.
NATURE IMMUNOLOGY (2018)
Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'
Sattva S. Neelapu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study
M. Thomas et al.
ANNALS OF ONCOLOGY (2018)
Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts
Martin P. Stewart et al.
CHEMICAL REVIEWS (2018)
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
Sarwish Rafiq et al.
NATURE BIOTECHNOLOGY (2018)
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell
Marco Ruella et al.
NATURE MEDICINE (2018)
SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study
Antoni Ribas et al.
CANCER DISCOVERY (2018)
Programming Cell-Cell Interactions through Non-genetic Membrane Engineering
Clifford M. Csizmar et al.
CELL CHEMICAL BIOLOGY (2018)
Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides
Chunsong Yu et al.
MOLECULAR PHARMACEUTICS (2017)
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
Kelly D. Moynihan et al.
NATURE MEDICINE (2016)
Clinical manufacturing of CAR T cells: foundation of a promising therapy
Xiuyan Wang et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
Toxicity and management in CAR T-cell therapy
Challice L. Bonifant et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
A Photoactivatable AIE Polymer for Light-Controlled Gene Delivery: Concurrent Endo/Lysosomal Escape and DNA Unpacking
Youyong Yuan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Paracrine co-delivery of TGF-beta and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells
Michael D. McHugh et al.
BIOMATERIALS (2015)
Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells
Zeguo Zhao et al.
CANCER CELL (2015)
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg et al.
SCIENCE (2015)
Microfluidic squeezing for intracellular antigen loading in polyclonal B-cells as cellular vaccines
Gregory Lee Szeto et al.
SCIENTIFIC REPORTS (2015)
Toll-like receptor agonist lipopeptides self-assemble into distinct nanostructures
Ian W. Hamley et al.
CHEMICAL COMMUNICATIONS (2014)
A Proteomic Ruler for Protein Copy Number and Concentration Estimation without Spike-in Standards
Jacek R. Wisniewski et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Kinetics of Tumor Destruction by Chimeric Antigen Receptor-modified T Cells
Usanarat Anurathapan et al.
MOLECULAR THERAPY (2014)
Structure-based programming of lymph-node targeting in molecular vaccines
Haipeng Liu et al.
NATURE (2014)
A lysosome-targeted drug delivery system based on sorbitol backbone towards efficient cancer therapy
Santhi Maniganda et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2014)
Early BCR events and antigen captutre, processing, and loading on MHC class II on B cells
Ana M. Avelos et al.
FRONTIERS IN IMMUNOLOGY (2014)
Facing the Truth about Nanotechnology in Drug Delivery
Kinam Park
ACS NANO (2013)
Palmitate-derivatized human IL-2: a potential anticancer immunotherapeutic of low systemic toxicity
Sharon H. Chou et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Genetically engineered T cells for the treatment of cancer
M. Essand et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Reactivation of latent HIV-1 in central memory CD4+ T cells through TLR-1/2 stimulation
Camille L. Novis et al.
RETROVIROLOGY (2013)
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway
Claudia Volpi et al.
NATURE COMMUNICATIONS (2013)
Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation
Anuradha Ray et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2013)
A DNA Nanostructure Platform for Directed Assembly of Synthetic Vaccines
Xiaowei Liu et al.
NANO LETTERS (2012)
DEC-205 is a cell surface receptor for CpG oligonucleotides
Mireille H. Lahoud et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A practical guide to evaluating colocalization in biological microscopy
Kenneth W. Dunn et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
Membrane Anchored Immunostimulatory Oligonucleotides for In Vivo Cell Modification and Localized Immunotherapy
Haipeng Liu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy
Brandon Kwong et al.
BIOMATERIALS (2011)
Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells
Hailing Lu et al.
CLINICAL CANCER RESEARCH (2011)
TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy
Hailing Lu et al.
CLINICAL CANCER RESEARCH (2011)
TLR1/TLR2 Agonist Induces Tumor Regression by Reciprocal Modulation of Effector and Regulatory T Cells
Yi Zhang et al.
JOURNAL OF IMMUNOLOGY (2011)
Amplifying TLR-MyD88 Signals within Tumor-Specific T Cells Enhances Antitumor Activity to Suboptimal Levels of Weakly Immunogenic Tumor Antigens
Degui Geng et al.
CANCER RESEARCH (2010)
TLR-9 signaling and TCR stimulation co-regulate CD8+ T cell-associated PD-1 expression
Raymond M. Wong et al.
IMMUNOLOGY LETTERS (2009)
Route of Administration of the TLR9 Agonist CpG Critically Determines the Efficacy of Cancer Immunotherapy in Mice
Stefan Nierkens et al.
PLOS ONE (2009)
Development of amphiphilic γ-PGA-nanoparticle based tumor vaccine:: Potential of the nanoparticulate cytosolic protein delivery carrier
Tomoaki Yoshikawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Targeting CpG oligonucleotides to the lymph node by nanoparticles elicits efficient antitumoral immunity
Carole Bourquin et al.
JOURNAL OF IMMUNOLOGY (2008)
Peptoidic amino- and guanidinium-carrier systems:: Targeted drug delivery into the cell cytosol or the nucleus
Tina Schroeder et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Arming tumor-reactive T cells with costimulator B7-1 enhances therapeutic efficacy of the T cells
Guoxing Zheng et al.
CANCER RESEARCH (2006)
Induction of proinflammatory responses in macrophages by the Glycosylphosphatidylinositols of Plasmodium falciparum -: Cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity
G Krishnegowda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
TLR2 is expressed on activated T cells as a costimulatory receptor
M Komai-Koma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells
EA Moseman et al.
JOURNAL OF IMMUNOLOGY (2004)
Simultaneous blocking of human toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guerin peptidoglycan
J Uehori et al.
INFECTION AND IMMUNITY (2003)
Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine
K Kunath et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Creating space: an antigen-independent, CpG-induced peripheral expansion of naive and memory T lymphocytes in a full T-cell compartment
E Davila et al.
BLOOD (2002)
Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides
V Hornung et al.
JOURNAL OF IMMUNOLOGY (2002)
分享论文
